In-Person Events
Amplify your reach through a tailored presence at our high-level events
10/04/24 - Zeno interrupts the dimerization of HER2 and HER3 and prevents NRG1/HER3 tumour signalling.
22/03/24 - Rare disease BPAN currently has no treatment options, this new research investigates whether antisense oligonucleotide therapies could be the answer to address this unmet need.
22/03/24 - Oligo sequencing revolutionizes biologics research, ensuring accurate analysis of oligonucleotides. Biologics by Oxford Global explores methods, safety, sustainability, and future trends. Despite challenges, advancements promise exciting opportunities for scientific discovery.
11/03/24 - Can oligonucleotide therapeutics shape the future of healthcare? We journey through AI frontiers, sustainable synthesis, and regulatory challenges.
05/03/24 - Read how innovators are transforming the industry towards one that prioritizes both healthy patients and a healthy planet.
28/02/24 - Recombinant and chemical peptide synthesis methods both have use cases in modern peptide production. Today the industry is looking to sustainable approaches to both.
